US5705485A
(en)
*
|
1987-09-18 |
1998-01-06 |
Ethicon, Inc. |
Gel formulations containing growth factors
|
US7056882B2
(en)
|
1991-03-11 |
2006-06-06 |
Curis, Inc. |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
|
US5674844A
(en)
*
|
1991-03-11 |
1997-10-07 |
Creative Biomolecules, Inc. |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
|
US5171579A
(en)
*
|
1991-10-11 |
1992-12-15 |
Genetics Institute, Inc. |
Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
|
US5385887A
(en)
*
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
AU689184B2
(en)
|
1993-12-07 |
1998-03-26 |
Genetics Institute, Llc |
BMP-12, BMP-13 and tendon-inducing compositions thereof
|
US6027919A
(en)
|
1993-12-07 |
2000-02-22 |
Genetics Institute, Inc. |
BMP-12 and BMP-13 proteins and DNA encoding them
|
WO1995024210A1
(en)
|
1994-03-08 |
1995-09-14 |
Genetics Institute, Inc. |
Methods and compositions for treatment of periodontal disease and repair of periodontal lesions
|
DE69528128T2
(de)
|
1994-06-10 |
2003-03-13 |
United States Surgical Corp |
Rekombinante Chimäre Proteine und Verfahren zur deren Verwendung
|
US5520923A
(en)
*
|
1994-09-19 |
1996-05-28 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
FR2726571B1
(fr)
*
|
1994-11-03 |
1997-08-08 |
Izoret Georges |
Colle biologique, procede de preparation et dispositif d'application pour colle biologique, et durcisseurs pour colle biologique
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
EP1364656B1
(en)
|
1995-06-05 |
2013-11-20 |
Genetics Institute, LLC |
Use of bone morphogenetic proteins for healing and repair of connective tissue attachment
|
US6352972B1
(en)
*
|
1995-06-06 |
2002-03-05 |
Marcel E. Nimni |
Bone morphogenetic proteins and their use in bone growth
|
US5674292A
(en)
|
1995-06-07 |
1997-10-07 |
Stryker Corporation |
Terminally sterilized osteogenic devices and preparation thereof
|
JPH09143093A
(ja)
|
1995-11-17 |
1997-06-03 |
Hoechst Japan Ltd |
軟骨・骨誘導性修復用材料
|
US6214796B1
(en)
|
1996-03-22 |
2001-04-10 |
The General Hospital Corporation |
Administration of polypeptide growth factors following central nervous system ischemia or trauma
|
US5700774A
(en)
*
|
1996-03-26 |
1997-12-23 |
Genetics Institute, Inc. |
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
|
US6492508B1
(en)
|
1996-06-03 |
2002-12-10 |
United States Surgical Corp. A Division Of Tyco Healthcare Group |
Nucleic acids encoding extracellular matrix proteins
|
GB9621825D0
(en)
*
|
1996-10-19 |
1996-12-11 |
Andaris Ltd |
Microparticles and their use as therapeutic vehicles
|
AU6245898A
(en)
*
|
1997-01-21 |
1998-08-07 |
Genetics Institute Inc. |
Injectable formulations for treatment of osteoporotic bone
|
KR100548107B1
(ko)
*
|
1997-01-30 |
2006-02-02 |
바이오팜 게젤샤프트 쭈어 바이오테히놀로지셴 엔트비클룽 폰 파르마카 엠베하 |
뼈 유도 인자 인간 mp52 동결 건조 조성물
|
US20040132653A1
(en)
*
|
1997-01-30 |
2004-07-08 |
Biopharm Gmbh |
Lyophilized composition of bone morphogenetic factor human MP52
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
EP0902036A1
(en)
|
1997-09-05 |
1999-03-17 |
Roche Diagnostics GmbH |
Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
|
FR2764514B1
(fr)
*
|
1997-06-13 |
1999-09-03 |
Biopharmex Holding Sa |
Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
|
DE19726412A1
(de)
*
|
1997-06-21 |
1998-12-24 |
Merck Patent Gmbh |
Implantatmaterial mit einer Träger-Wirkstoff-Kombination
|
CA2297489A1
(en)
|
1997-07-30 |
1999-02-11 |
Emory University |
Novel bone mineralization proteins, dna, vectors, expression systems
|
US7923250B2
(en)
|
1997-07-30 |
2011-04-12 |
Warsaw Orthopedic, Inc. |
Methods of expressing LIM mineralization protein in non-osseous cells
|
US6911553B1
(en)
|
1997-10-02 |
2005-06-28 |
Roche Diagnostics Gmbh |
Osteoblast-specific mitogens and drugs containing such compounds
|
EP0906759A1
(de)
|
1997-10-02 |
1999-04-07 |
Roche Diagnostics GmbH |
Neue Osteoblastenspezifische Mitogene: Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
US6767892B1
(en)
*
|
1997-11-07 |
2004-07-27 |
Chrion Corporation |
Compositions providing for increased IGF-I solubility
|
AU752816B2
(en)
|
1997-11-28 |
2002-10-03 |
Curis, Inc. |
An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
|
WO1999030632A1
(en)
*
|
1997-12-18 |
1999-06-24 |
Comfort Biomedical, Inc. |
Bone augmentation for prosthetic implants and the like
|
US6214049B1
(en)
|
1999-01-14 |
2001-04-10 |
Comfort Biomedical, Inc. |
Method and apparatus for augmentating osteointegration of prosthetic implant devices
|
US20030147860A1
(en)
|
2002-02-07 |
2003-08-07 |
Marchosky J. Alexander |
Compositions and methods for forming and strengthening bone
|
US6849255B2
(en)
|
1998-08-18 |
2005-02-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods and compositions for enhancing cartilage repair
|
US6630457B1
(en)
*
|
1998-09-18 |
2003-10-07 |
Orthogene Llc |
Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
|
CN1321094A
(zh)
*
|
1998-09-30 |
2001-11-07 |
武田药品工业株式会社 |
骨修复材料和人造骨组合物
|
US6663870B2
(en)
|
1998-12-07 |
2003-12-16 |
Zymogenetics, Inc. |
Methods for promoting growth of bone using zvegf3
|
DE19906096A1
(de)
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US6468543B1
(en)
|
1999-05-03 |
2002-10-22 |
Zymogenetics, Inc. |
Methods for promoting growth of bone using ZVEGF4
|
CA2377435A1
(en)
|
1999-06-29 |
2001-01-04 |
J. Alexander Marchosky |
Compositions and methods for forming and strengthening bone
|
AU2000251259A1
(en)
*
|
2000-02-04 |
2001-08-14 |
Zymogenetics Inc. |
Methods for promoting growth of bone, ligament, and cartilage using zvegf4
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
WO2002034172A1
(en)
*
|
2000-10-24 |
2002-05-02 |
Sdgi Holdings, Inc. |
Osteogenic packing device and method
|
AU3649502A
(en)
|
2000-11-29 |
2002-06-11 |
Oculex Pharm Inc |
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
US6949251B2
(en)
*
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
EP1409647A4
(en)
|
2001-04-30 |
2009-09-09 |
Yissum Res Dev Co |
COMPOSITE SKELETONS AND METHODS OF USE THEREOF FOR GENERATING COMPLEX TISSUE GRAFT
|
TWI267378B
(en)
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
JP4614661B2
(ja)
*
|
2002-02-08 |
2011-01-19 |
ワイス |
生体活性因子を含有する処方物およびそれを使用する方法
|
EP1478415A1
(en)
*
|
2002-02-22 |
2004-11-24 |
Biomatera Inc. |
Biodegradable bone implant
|
CA2493871A1
(en)
|
2002-07-16 |
2004-01-22 |
Hadi Aslan |
Methods of implanting mesenchymal stem cells for tissue repair and formation
|
US20040023322A1
(en)
*
|
2002-08-01 |
2004-02-05 |
Goodheart Clyde R. |
Method of producing non-recombinant BMP-2 and use thereof
|
US20050048099A1
(en)
*
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
US20050003007A1
(en)
*
|
2003-07-02 |
2005-01-06 |
Michele Boix |
Method of sterilization of polymeric microparticles
|
US7141544B2
(en)
*
|
2003-10-10 |
2006-11-28 |
Baxter International, Inc. |
Stabilization of pharmaceutical protein formulations with small peptides
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
CA2553381C
(en)
|
2004-01-20 |
2011-03-22 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US8147865B2
(en)
*
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
ATE462451T1
(de)
*
|
2004-06-16 |
2010-04-15 |
Affinergy Inc |
Grenzflächenbiomaterialien zur förderung der anhaftung von zielanalyten
|
US8512730B2
(en)
|
2004-07-12 |
2013-08-20 |
Isto Technologies, Inc. |
Methods of tissue repair and compositions therefor
|
EP2216026B1
(en)
*
|
2004-07-12 |
2016-04-20 |
Allergan, Inc. |
Ophthalmic compositions and uses for treating ophthalmic conditions
|
US8192759B2
(en)
*
|
2004-07-12 |
2012-06-05 |
Isto Technologies, Inc. |
Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20060258578A1
(en)
*
|
2005-05-10 |
2006-11-16 |
The University Of Zurich |
Pharmaceutical composition
|
US20060286171A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Tianhong Zhou |
Bone morphogenetic protein formulations
|
EP1973554B1
(en)
*
|
2005-12-07 |
2015-01-14 |
Isto Technologies Inc. |
Cartilage repair methods
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
AU2007254824A1
(en)
|
2006-06-02 |
2007-12-13 |
Wyeth |
Use of proteins and peptides of the TGF-beta superfamily for purification and therapeutic methods
|
US7754689B2
(en)
|
2006-06-02 |
2010-07-13 |
Wyeth Llc |
Finger-1 peptide analogs of the TGF-β superfamily
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
DE102006060958A1
(de)
*
|
2006-12-20 |
2008-06-26 |
Jennissen, Herbert P., Prof. Dr. |
Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
AU2008255016B2
(en)
*
|
2007-05-15 |
2013-05-09 |
Stryker Corporation |
Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
|
DE102007051914A1
(de)
*
|
2007-10-29 |
2009-05-07 |
Herbert Prof. Dr. Jennissen |
Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
|
US8764350B2
(en)
|
2008-06-05 |
2014-07-01 |
Alstom Technology Ltd |
Conveyor for transporting powder, and a method for conveying powder
|
JP5982287B2
(ja)
|
2009-11-09 |
2016-08-31 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
発毛を刺激する組成物および方法
|
WO2011143226A1
(en)
|
2010-05-11 |
2011-11-17 |
Howmedica Osteonics Corp. |
Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
|
JP2012082180A
(ja)
*
|
2010-10-14 |
2012-04-26 |
Nagoya Univ |
骨再生用自己組織化ペプチドハイドロゲル
|
US8765189B2
(en)
|
2011-05-13 |
2014-07-01 |
Howmedica Osteonic Corp. |
Organophosphorous and multivalent metal compound compositions and methods
|
DK2851085T3
(da)
|
2012-05-14 |
2019-09-09 |
Teijin Ltd |
Proteinsammensætning steriliseret ved stråling
|
US10245306B2
(en)
|
2012-11-16 |
2019-04-02 |
Isto Technologies Ii, Llc |
Flexible tissue matrix and methods for joint repair
|
RU2641021C2
(ru)
|
2013-02-15 |
2018-01-17 |
Аллерган, Инк. |
Имплантат для пролонгированной доставки лекарственного средства
|
US20180169041A1
(en)
|
2014-03-20 |
2018-06-21 |
Stayble Therapeutics Ab |
Composition for use in the treatment of intervertebral disc-related pain
|
US10179191B2
(en)
|
2014-10-09 |
2019-01-15 |
Isto Technologies Ii, Llc |
Flexible tissue matrix and methods for joint repair
|
US10195305B2
(en)
*
|
2015-03-24 |
2019-02-05 |
Orthovita, Inc. |
Bioactive flowable wash-out resistant bone graft material and method for production thereof
|
WO2017046030A1
(en)
|
2015-09-14 |
2017-03-23 |
Stayble Therapeutics Ab |
A composition for use in the treatment of intervertebral disc-related pain
|
JP6901721B2
(ja)
*
|
2017-03-30 |
2021-07-14 |
国立大学法人東海国立大学機構 |
骨髄止血剤
|
KR102066392B1
(ko)
|
2017-11-14 |
2020-01-16 |
한국치아은행 주식회사 |
골 이식용 복합체 제조방법 및 이에 의해 제조된 골 이식용 복합체
|
CN109125791B
(zh)
*
|
2018-09-29 |
2019-08-30 |
广州贝奥吉因生物科技有限公司 |
一种具有促进骨修复功能的可吸收骨蜡及制备方法
|
EP3936165A1
(en)
*
|
2020-07-10 |
2022-01-12 |
MedPark Co., Ltd. |
Method for preparing bone graft composition and bone graft composition
|